Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P10145 (
IL-8
)
23,849
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Activation of transcription by NF-kappaB requires association with coactivator proteins, including CBP/p300 and P/CAF. To identify new coregulatory proteins, a cytoplasmic two-hybrid screen was performed using the C-terminus of the p65 subunit as bait. Through this screen, the spermidine/spermine N(1)-acetyltransferase 2 (
SSAT2
) protein was identified as a potential modulator of NF-kappaB activity.
SSAT2
was originally identified based on homology to SSAT1, a protein involved in polyamine catabolism. However both proteins contain an acetyltransferase domain that has similarity to the acetyltransferase domains of the GNAT superfamily of coactivators. Although
SSAT2
is 46% identical to SSAT1, based on a recent report,
SSAT2
does not appear to function in polyamine catabolism. Because of the similarity of
SSAT2
to coactivators, we wanted to determine if
SSAT2
could function as a coactivator for NF-kappaB. Coimmunoprecipitations confirmed the interaction between p65 and
SSAT2
. In transient transfection reporter gene assays,
SSAT2
functions as a transcriptional coactivator for NF-kappaB and cooperates with CBP and P/CAF to enhance TNFalpha-induced NF-kappaB activity. Moreover,
SSAT2
transiently associates with the promoters of the NF-kappaB-regulated cIAP2 and
IL-8
genes in response to TNFalpha. Although the overall function of
SSAT2
is not known, it appears that it can function as a transcriptional coactivator.
...
PMID:Spermidine/Spermine N1-Acetyltransferase 2 (SSAT2) functions as a coactivator for NF-kappaB and cooperates with CBP and P/CAF to enhance NF-kappaB-dependent transcription. 1701 43